GENREXVY Trademark

Trademark Overview


On Friday, March 3, 2023, a trademark application was filed for GENREXVY with the United States Patent and Trademark Office. The USPTO has given the GENREXVY trademark a serial number of 97822931. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, January 26, 2024. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The GENREXVY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery

Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of metabolic and rare metabolic and genetic diseases and disorders

Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, and metabolic and rare metabolic and genetic diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical, scientific, and medical research, namely, compiling and sharing of patient data for research purposes in the field of metabolic and rare metabolic and genetic diseases and disorders; providing medical and scientific research information in the field of metabolic and rare metabolic and genetic diseases and disorders
genrexvy

General Information


Serial Number97822931
Word MarkGENREXVY
Filing DateFriday, March 3, 2023
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, January 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery
Goods and ServicesProviding medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of metabolic and rare metabolic and genetic diseases and disorders
Goods and ServicesPharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, and metabolic and rare metabolic and genetic diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical, scientific, and medical research, namely, compiling and sharing of patient data for research purposes in the field of metabolic and rare metabolic and genetic diseases and disorders; providing medical and scientific research information in the field of metabolic and rare metabolic and genetic diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateFriday, January 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateFriday, January 26, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events


Event DateEvent Description
Wednesday, March 27, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, January 26, 2024ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Thursday, January 25, 2024TEAS EXPRESS ABANDONMENT RECEIVED
Friday, January 26, 2024ABANDONMENT - AFTER PUBLICATION
Wednesday, December 13, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 24, 2023NON-FINAL ACTION E-MAILED
Sunday, September 24, 2023NON-FINAL ACTION WRITTEN
Thursday, September 21, 2023ASSIGNED TO EXAMINER
Friday, March 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 7, 2023NEW APPLICATION ENTERED